Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2006; 12(34): 5544-5549
Published online Sep 14, 2006. doi: 10.3748/wjg.v12.i34.5544
Published online Sep 14, 2006. doi: 10.3748/wjg.v12.i34.5544
Table 3 Influence of clinical and histological variables on therapeutic success
Eradication rate (%) | Odds ratio1 | 95% CI | P | |
Demographic data | ||||
Female gender | 66.7 | 0.33 | 0.03-2.18 | 0.27 |
Age ≤ 10 yr | 66.7 | 0.56 | 0.1-3.11 | 0.47 |
Indication for treatment | ||||
Ulcer-like functional dyspepsia | 65.5 | 0.00 | 0.0-1.23 | 0.08 |
Initial endoscopy | ||||
Normal examination | 76.9 | 1.30 | 0.23-9.44 | 1 |
Nodular gastritis2 | 56.2 | 0.24 | 0.03-1.39 | 0.08 |
Duodenal ulcer or erosive bulbitis | 100 | undefined | undefined | 0.16 |
Histology | ||||
Intense activity | 70.0 | 0.70 | 0.13-5.97 | 1 |
Moderate activity | 78.9 | 1.73 | 0.32-10.17 | 0.46 |
Light activity | 66.7 | 0.67 | 0.10-5.28 | 0.68 |
Intense density | 75.0 | 1.09 | 0.15-13.19 | 1 |
Moderate density | 73.7 | 1.00 | 0.18-5.45 | 1 |
Light density | 72.7 | 0.93 | 0.16-7.01 | 1 |
Adverse effects | ||||
Yes | 76.9 | 1.67 | 0.27-9.37 | 0.69 |
- Citation: Kawakami E, Machado RS, Ogata SK, Langner M, Fukushima E, Carelli AP, Bonucci VCG, Patrício FRS. Furazolidone-based triple therapy for H pylori gastritis in children. World J Gastroenterol 2006; 12(34): 5544-5549
- URL: https://www.wjgnet.com/1007-9327/full/v12/i34/5544.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i34.5544